Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA.
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Neurogastroenterol Motil. 2019 Sep;31(9):e13678. doi: 10.1111/nmo.13678. Epub 2019 Jul 16.
BACKGROUND: Esophageal hypercontractility can manifest with and without esophagogastric junction (EGJ) outflow obstruction. We investigated clinical presentations and motility patterns in patients with esophageal hypercontractile disorders. METHODS: Esophageal HRM studies fulfilling Chicago Classification 3.0 criteria for jackhammer esophagus (distal contractile integral, DCI >8000 mmHg.cm.s in ≥ 20% swallows) with (n = 30) and without (n = 83) EGJ obstruction (integrated relaxation pressure, IRP > 15 mm Hg) were retrospectively reviewed from five centers (4 in Europe, 1 in US). Single swallows (SS) and multiple rapid swallows (MRS) were analyzed using HRM software tools (IRP, DCI, distal latency, DL); MRS: SS DCI ratio >1 defined contraction reserve. Comparison groups were achalasia type 3 (n = 72, positive control for abnormal inhibition and EGJ obstruction) and healthy controls (n = 18). Symptoms, HRM metrics, and MRS contraction reserve were analyzed within jackhammer subgroups and comparison groups. KEY RESULTS: The esophageal smooth muscle was excessively stimulated at baseline in jackhammer subgroups, with lack of augmentation following MRS identified more often compared with controls (P = .003) and type 3 achalasia (P = .07). Consistently abnormal inhibition was identified in type 3 achalasia (47%), and to a lower extent in jackhammer with obstruction (37%, P = .33), jackhammer esophagus (28%, P = .01), and controls (11%, P < .01 compared with type 3 achalasia). Perceptive symptoms (heartburn, chest pain) were common in jackhammer esophagus (P < .01 compared with type 3 achalasia), while transit symptoms (dysphagia) were more frequent with presence of EGJ obstruction (P ≤ .01 compared with jackhammer without obstruction). CONCLUSIONS AND INFERENCES: The balance of excessive excitation and abnormal inhibition defines clinical and manometric manifestations in esophageal hypercontractile disorders.
背景:食管高收缩性可表现为伴有或不伴有食管胃结合部(EGJ)流出道梗阻。我们研究了食管高收缩性疾病患者的临床表现和动力模式。
方法:从五个中心(欧洲 4 个,美国 1 个)回顾性分析符合芝加哥分类 3.0 标准的食管高收缩性疾病(远端收缩积分,DCI>8000mmHg·cm·s,≥20%吞咽次数)的食管高收缩性疾病(DCI>8000mmHg·cm·s,≥20%吞咽次数)患者(n=30)和无 EGJ 梗阻(整合松弛压力,IRP>15mmHg)的食管 HRM 研究(n=83)。使用 HRM 软件工具(IRP、DCI、远端潜伏期、DL)分析单次吞咽(SS)和多次快速吞咽(MRS);MRS:SS DCI 比值>1 定义收缩储备。比较组为贲门失弛缓症 3 型(n=72,异常抑制和 EGJ 梗阻的阳性对照)和健康对照组(n=18)。分析 jackhammer 亚组和比较组内的症状、HRM 指标和 MRS 收缩储备。
主要结果:jackhammer 亚组在基础状态下食管平滑肌过度兴奋,与对照组相比(P=.003)和 3 型贲门失弛缓症(P=.07)相比,MRS 后缺乏增强更为常见。3 型贲门失弛缓症(47%)和程度较低的 jackhammer 伴梗阻(37%,P=.33)、jackhammer 食管(28%,P=.01)和对照组(11%,与 3 型贲门失弛缓症相比,P<.01)存在一致的异常抑制。食管高收缩性疾病(P<.01)与 3 型贲门失弛缓症相比),而 EGJ 梗阻时更常出现转运症状(吞咽困难)(与无梗阻的 jackhammer 相比,P≤.01)。
结论和推论:在食管高收缩性疾病中,过度兴奋和异常抑制的平衡决定了临床和测压表现。
Am J Physiol Gastrointest Liver Physiol. 2018-12-13
Neurogastroenterol Motil. 2017-3
Neurogastroenterol Motil. 2015-2
Neurogastroenterol Motil. 2017-4
Am J Physiol Gastrointest Liver Physiol. 2017-12-21
Am J Physiol Gastrointest Liver Physiol. 2017-7-1
United European Gastroenterol J. 2024-9
Am J Physiol Gastrointest Liver Physiol. 2024-4-1
Neurogastroenterol Motil. 2024-1
Gastroenterol Hepatol (N Y). 2021-10
J Neurogastroenterol Motil. 2022-1-30
J Neurogastroenterol Motil. 2021-10-30
J Neurogastroenterol Motil. 2021-10-30
J Neurogastroenterol Motil. 2021-7-30
Neurogastroenterol Motil. 2021-11
Neurogastroenterol Motil. 2020-11